Exelixis Inc
NASDAQ:EXEL

Watchlist Manager
Exelixis Inc Logo
Exelixis Inc
NASDAQ:EXEL
Watchlist
Price: 35.61 USD 2.24% Market Closed
Market Cap: 10.2B USD
Have any thoughts about
Exelixis Inc?
Write Note

P/OCF
Price to OCF

21.6
Current
17.2
Median
21.6
Industry
Higher than median
Higher than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
21.6
=
Market Cap
10.1B USD
/
Operating Cash Flow
470.2m USD
All Countries
Close
Market Cap P/OCF
US
Exelixis Inc
NASDAQ:EXEL
10.1B USD 21.6
FR
Pharnext SCA
OTC:PNEXF
6T USD -238 094.9
US
Abbvie Inc
NYSE:ABBV
314.7B USD 18.9
US
Amgen Inc
NASDAQ:AMGN
157B USD 21.8
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
115.9B USD -137.6
US
Gilead Sciences Inc
NASDAQ:GILD
112.2B USD 11.2
US
Epizyme Inc
F:EPE
94.1B EUR -472.5
AU
CSL Ltd
ASX:CSL
133.6B AUD 31.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD 19.5
US
Seagen Inc
F:SGT
39.3B EUR -76.3
NL
argenx SE
XBRU:ARGX
34.5B EUR -139.4

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More